Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignace Vergote

Showing results (521-530 of 578) with videos related to

Pageof 58
Sort By:
Canadian Journal of Surgery. Journal Canadien De Chirurgie|June 27, 2023
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysisTaymaa May, Marcus Bernardini, Stephanie Lheureux, et al.
Gynecologic Oncology|August 7, 2013
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome AtlasSharon E Johnatty, Jonathan Beesley, Bo Gao, et al.
Nature Genetics|April 19, 2011
Genome-wide association study identifies a common variant associated with risk of endometrial cancerAmanda B Spurdle, Deborah J Thompson, Shahana Ahmed, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
Journal of the National Cancer Institute|June 25, 2014
ABCA transporter gene expression and poor outcome in epithelial ovarian cancerEllen L Hedditch, Bo Gao, Amanda J Russell, et al.
Oncotarget|October 15, 2017
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome lociDylan M Glubb, Sharon E Johnatty, Michael C J Quinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2021
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V IIMaaike H M Oonk, Brian Slomovitz, Peter J W Baldwin, et al.
Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.
Plos One|June 4, 2011
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association ConsortiumErnest K Amankwah, Qinggang Wang, Joellen M Schildkraut, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
Pageof 58

Showing results (521-530 of 578) with videos related to

Sort By:
Pageof 58
Canadian Journal of Surgery. Journal Canadien De Chirurgie|June 27, 2023
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysisTaymaa May, Marcus Bernardini, Stephanie Lheureux, et al.
Gynecologic Oncology|August 7, 2013
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome AtlasSharon E Johnatty, Jonathan Beesley, Bo Gao, et al.
Nature Genetics|April 19, 2011
Genome-wide association study identifies a common variant associated with risk of endometrial cancerAmanda B Spurdle, Deborah J Thompson, Shahana Ahmed, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
Journal of the National Cancer Institute|June 25, 2014
ABCA transporter gene expression and poor outcome in epithelial ovarian cancerEllen L Hedditch, Bo Gao, Amanda J Russell, et al.
Oncotarget|October 15, 2017
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome lociDylan M Glubb, Sharon E Johnatty, Michael C J Quinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2021
Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V IIMaaike H M Oonk, Brian Slomovitz, Peter J W Baldwin, et al.
Plos One|September 28, 2011
Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancersJonathan Beesley, Hilda A Pickett, Sharon E Johnatty, et al.
Plos One|June 4, 2011
Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association ConsortiumErnest K Amankwah, Qinggang Wang, Joellen M Schildkraut, et al.
Oncotarget|February 4, 2016
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerJuliet D French, Sharon E Johnatty, Yi Lu, et al.
Pageof 58